hydroxychloroquine has been researched along with DRESS Syndrome in 6 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Background: Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome) or drug-induced hypersensitivity (DIHS) is a rare and feared complication of frequently used medications such as anticonvulsants, sulfonamides, and allopurinol." | 5.51 | Pustular DRESS Syndrome Secondary to Hydroxychloroquine With EBV Reactivation ( Girijala, RL; Goldberg, LH; Kwak, Y; Patel, DB; Siddiqi, I; Wright, D, 2019) |
| " Current Condition: He started 8 days after ingestion of hydroxychloroquine for probable SARS-COV-2 infection, with headache, facial and neck edema, desquamative dermatosis on trunk and upper extremities, went to private clinic with torpid evolution sent to third level for increased facial and neck edema, which merited orotracheal intubation, management with intravenous steroids and antihistamines." | 4.31 | [Caso clínico: síndrome de DRESS por hidroxicloroquina]. ( Armenta-Morales, J; Caballero-López, C; López-García, A; Pacheco-Jiménez, Y; Papaqui-Tapia, J; Ríos-López, J; Rivero-Yeverino, D, 2023) |
| " This patient was diagnosed with drug rash with eosinophilia and systemic symptoms syndrome 4 weeks after starting sulfasalazine and 5 weeks after starting hydroxychloroquine for rheumatoid arthritis." | 4.12 | Drug rash with eosinophilia and systemic symptoms syndrome masquerading as a lymphoproliferative disorder in a young adult on immunosuppressive therapy for rheumatoid arthritis: a case report. ( Hyser, E, 2022) |
| "Background: Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome) or drug-induced hypersensitivity (DIHS) is a rare and feared complication of frequently used medications such as anticonvulsants, sulfonamides, and allopurinol." | 1.51 | Pustular DRESS Syndrome Secondary to Hydroxychloroquine With EBV Reactivation ( Girijala, RL; Goldberg, LH; Kwak, Y; Patel, DB; Siddiqi, I; Wright, D, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hyser, E | 1 |
| Pacheco-Jiménez, Y | 1 |
| Ríos-López, J | 1 |
| Caballero-López, C | 1 |
| López-García, A | 1 |
| Rivero-Yeverino, D | 1 |
| Papaqui-Tapia, J | 1 |
| Armenta-Morales, J | 1 |
| Schwartz, RA | 1 |
| Janniger, CK | 1 |
| Grandolfo, M | 1 |
| Romita, P | 1 |
| Bonamonte, D | 1 |
| Cazzato, G | 1 |
| Hansel, K | 1 |
| Stingeni, L | 1 |
| Conforti, C | 1 |
| Giuffrida, R | 1 |
| Foti, C | 1 |
| Castro Jiménez, A | 1 |
| Navarrete Navarrete, N | 1 |
| Gratacós Gómez, AR | 1 |
| Florido López, F | 1 |
| García Rodríguez, R | 1 |
| Gómez Torrijos, E | 1 |
| Girijala, RL | 1 |
| Siddiqi, I | 1 |
| Kwak, Y | 1 |
| Wright, D | 1 |
| Patel, DB | 1 |
| Goldberg, LH | 1 |
1 review available for hydroxychloroquine and DRESS Syndrome
| Article | Year |
|---|---|
Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine.
Topics: Acute Generalized Exanthematous Pustulosis; Adrenal Cortex Hormones; Coronavirus Infections; COVID-1 | 2020 |
5 other studies available for hydroxychloroquine and DRESS Syndrome
| Article | Year |
|---|---|
Drug rash with eosinophilia and systemic symptoms syndrome masquerading as a lymphoproliferative disorder in a young adult on immunosuppressive therapy for rheumatoid arthritis: a case report.
Topics: Adult; Anti-Bacterial Agents; Arthritis, Rheumatoid; Drug Hypersensitivity Syndrome; Eosinophilia; E | 2022 |
[Caso clínico: síndrome de DRESS por hidroxicloroquina].
Topics: Adult; Drug Hypersensitivity Syndrome; Edema; Eosinophilia; Humans; Hydroxychloroquine; Male; Steroi | 2023 |
Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era.
Topics: Aged; Antimalarials; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dru | 2020 |
First case of DRESS syndrome caused by hydroxychloroquine with a positive patch test.
Topics: Adult; Drug Hypersensitivity Syndrome; Eosinophilia; Female; Humans; Hydroxychloroquine; Middle Aged | 2021 |
Pustular DRESS Syndrome Secondary to Hydroxychloroquine With EBV Reactivation
Topics: Administration, Cutaneous; Antimalarials; Drug Hypersensitivity Syndrome; Epstein-Barr Virus Infecti | 2019 |